Live News NEWS FLASH L impact Sep 23, 2026, 09:07 PM UTC Arcturus Therapeutics Announces Encouraging Interim Phase 2 Results From Arct-810 In Otc Deficiency Arcturus Therapeutics Holdings Inc NASDAQ:ARCT ARCT SquawkNews Newsroom